Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 163
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

A Modification to Homeopathic Drug Carcinosin

Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...

Mathematical model to reduce maternal and infant mortality in Southeast Asia

Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...

Backer Badge Funded